Get App

GlaxoSmithKline Pharma q3 net declines 72%

​​Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.
  • Updated On Feb 13, 2024 at 06:30 AM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
GlaxoSmithKline Pharmaceuticals on Monday said its consolidated net profit declined 72% to ₹46 crore for the December quarter.

The drug firm had reported a net profit of ₹165 crore in the year-ago period.

Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.

  • Published On Feb 13, 2024 at 06:30 AM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App